deltatrials
Terminated PHASE1 INTERVENTIONAL 1-arm NCT02601274

Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor (HMPL-309)

Open-label, Dose Escalation Phase I Study of Theliatinib (HMPL-309,Xiliertinib) in Patients With Advanced Solid Tumors

Sponsor: Hutchison Medipharma Limited

Conditions Cancer
Interventions Theliatinib
Updated 11 times since 2017 Last updated: Feb 22, 2019 Started: Apr 30, 2015 Primary completion: Dec 31, 2018 Completion: Dec 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

the change of clinical development plan

Other terminated trials from Hutchison Medipharma Limited

More terminations from Hutchison Medipharma Limited

Other Cancer trials with similar outcome

Browse all Cancer trials

A PHASE1 clinical study on Cancer, this trial is terminated or withdrawn. The trial is conducted by Hutchison Medipharma Limited and has accumulated 11 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotRecruiting~Sep 2018 – ~Jan 2019 · 4 months · monthly snapshotRecruiting~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshotRecruiting~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshotRecruiting~Mar 2019 – ~Jan 2021 · 22 months · monthly snapshotTerminated~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotTerminated~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  3. Nov 2022 — Jul 2024 [monthly]

    Terminated PHASE1

  4. Jan 2021 — Nov 2022 [monthly]

    Terminated PHASE1

  5. Mar 2019 — Jan 2021 [monthly]

    Terminated PHASE1

    Status: Recruiting → Terminated

▶ Show 6 earlier versions

  1. Feb 2019 — Mar 2019 [monthly]

    Recruiting PHASE1

  2. Jan 2019 — Feb 2019 [monthly]

    Recruiting PHASE1

  3. Sep 2018 — Jan 2019 [monthly]

    Recruiting PHASE1

  4. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE1

  5. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

  6. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hutchison Medipharma Limited
Data source: Hutchmed

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations